-
Signature
-
/s /Drew Parkes, Attorney-in-Fact for Belsky Scott
-
Issuer symbol
-
TEAM
-
Transactions as of
-
01 Oct 2025
-
Transactions value $
-
$239,752
-
Form type
-
4
-
Filing time
-
02 Oct 2025, 17:54:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Belsky Scott |
Director |
C/O ATLASSIAN CORPORATION, 350 BUSH STREET, FLOOR 13, SAN FRANCISCO |
/s /Drew Parkes, Attorney-in-Fact for Belsky Scott |
02 Oct 2025 |
0001674730 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$31K |
+200 |
+13.75% |
$155.08 |
1.66K |
01 Oct 2025 |
See Footnote |
F1, F2, F3 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$45.2K |
+300 |
+18.13% |
$150.81 |
1.96K |
01 Oct 2025 |
See Footnote |
F1, F3, F4 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$32.2K |
+200 |
+10.23% |
$161.14 |
2.16K |
01 Oct 2025 |
See Footnote |
F1, F3, F5 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$15.9K |
+100 |
+4.64% |
$159.49 |
2.26K |
01 Oct 2025 |
See Footnote |
F1, F3 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$30.5K |
+200 |
+8.87% |
$152.48 |
2.46K |
01 Oct 2025 |
See Footnote |
F1, F3, F6 |
| transaction |
TEAM |
Class A Common Stock |
Purchase |
$84.8K |
+566 |
+23.05% |
$149.86 |
3.02K |
01 Oct 2025 |
See Footnote |
F1, F3, F7 |
| holding |
TEAM |
Class A Common Stock |
|
|
|
|
|
1.63K |
01 Oct 2025 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: